Jonathan Trent, MD, PhD, serves as a professor of medicine, associate director of clinical research, and director of the Bone and Soft-Tissue Sarcoma Group at the Sylvester Comprehensive Cancer Center of the University of Miami Health System in Miami, Florida.
Biomarker Analysis Shows Better Outcomes for Undetectable ctDNA in GIST
July 6th 2023Jonathan C. Trent, MD, PhD, discusses the molecular analyses of the INTRIGUE study, which was supported by Caris Life Science’s Precision Oncology Alliance, investigating patients with GIST that were presented at ASCO 2023.
Significance of the NCI Molecular Analysis for Therapy Choice Program
June 10th 2015Jonathan C. Trent, MD, PhD, professor of medicine, co-director, Musculoskeletal Center, Sarcoma Medical Research Program, Sylvester Comprehensive Cancer Center, University of Miami Health System, gives an overview of the NCI Molecular Analysis for Therapy Choice Program (MATCH).